Gain an advantage from both sides: Smart size-shrinkable drug delivery nanosystems for high accumulation and deep penetration

Shuang Bai,Yang Zhang,Dengfeng Li,Xiaoxiao Shi,Gan Lin,Gang Liu
DOI: https://doi.org/10.1016/j.nantod.2020.101038
IF: 17.4
2021-01-01
Nano Today
Abstract:The first generation of nanomedicine exhibits superior performance in the clinical treatment of various cancers compared to free conventional anticancer therapeutics. However, poor tumor penetration has been considered a major obstacle in the cancer treatment process and substantially impairs the overall therapeutic efficacy. Recently, this situation has been effectively improved through a great variety of smart size shrinkable drug delivery nanosystems (SSDDNs), which remains stable with relatively large size in the circulation system for a prolonged plasma half-life and enhanced tumor accumulation, then specifically turn into smaller particles at the tumor site by an appropriate stimulus to promote tumor penetration for uniform drug distribution throughout the whole tumor. In this review, we systematically summarize the intelligent size-shrinkable strategies mediated by different response modes, including endogenous and external stimuli. In addition to offering enhanced penetration, the size-shrinkable strategy can companion imaging probes for specific diagnoses and image-guided therapy. The challenges and prospects are discussed, and several proposals for promoting SSDDNs clinical translation are supplied. It is anticipated that such smart SSDDNs will provide a guideline for next-generation clinical translation. (C) 2020 Elsevier Ltd. All rights reserved.
What problem does this paper attempt to address?